Health
Push to get $3.5m drug approved to save kids’ lives – Fraser Coast Chronicle
Parents are fighting to make breakthrough gene therapy — which costs $3.5m for a one-off dose — affordable, and to have all Aussie kids screened.
It is one of the most expensive drugs to ever hit the market, but at $3.5 million per one-off dose, it can mean the difference between life and death for a baby born with spinal muscular atrophy (SMA).
Zolgensma, a gene therapy, is approved by the Therapeutic Good Administration (TGA) but is currently facing a Pharmaceutical Benefits Advisory Board (PBAC) decision on whether to list it for subsidy on the Pharmaceutical Benefits Scheme.
One in 35 people carry the gene mutation for SMA.
SMA leads…
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General16 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
General11 hours agoPerth man charged after investigation into organised crime and tobacco store attacks